Weave Communications, Inc.
$5.47
▲
3.59%
2026-04-21 10:14:01
www.getweave.com
NYQ: WEAV
Explore Weave Communications, Inc. stock price, valuation, financial statements, dividend history, analyst estimates, and long-term business fundamentals on StockSifting.
Market Cap
$430.21 M
Current Price
$5.47
52W High / Low
$11.32 / $4.24
Stock P/E
—
Book Value
$1.05
Dividend Yield
—
ROCE
-24.81%
ROE
-37.56%
Face Value
—
EPS
$-0.37
Exp Qtr EPS
—
Sector
Healthcare
Industry
Health Information Services
Employees
904
Beta
1.71
Debt / Equity
63.3
Current Ratio
1.24
Quick Ratio
1.24
Forward P/E
22.31
Price / Sales
1.52
Enterprise Value
$334.58 M
EV / EBITDA
-17.71
EV / Revenue
1.4
Rating
Strong Buy
Target Price
$8.75
EPS Forecast (FY)
—
Pros
- Short-term liquidity looks comfortable.
Cons
- Return on equity is on the weaker side.
- Capital efficiency is modest.
- Operating margin is thin.
- Net margin is relatively low.
Sift Stocks
| S.No. | Name | Price | P.E. | Market Cap | Div Yld % | ROCE | ROE | 52Week High/ Low | Book Value |
|---|---|---|---|---|---|---|---|---|---|
| 1. | SCWorx Corp. | $1.05 | — | $1.18 M | — | -27.93% | -76.35% | $13.05 / $0.76 | $0.52 |
| 2. | Teladoc Health, Inc. | $6.1 | — | $1.09 B | — | -6.66% | -13.93% | $9.77 / $4.4 | $7.77 |
| 3. | Health Catalyst, Inc. | $1.26 | — | $92.72 M | — | -10.35% | -58.26% | $5.06 / $0.96 | $3.41 |
| 4. | Mangoceuticals, Inc. | $0.51 | — | $7.43 M | — | -62.34% | -1.42% | $2.88 / $0.16 | $1.13 |
| 5. | American Well Corporation | $6.61 | — | $101.3 M | — | -42.01% | -33.67% | $9.15 / $3.71 | $14.34 |
| 6. | GoodRx Holdings, Inc. | $2.37 | 26.67 | $811.9 M | — | 7.56% | 4.54% | $5.81 / $1.77 | $1.81 |
| 7. | Definitive Healthcare Corp. | $1.05 | — | $147.1 M | — | -3.56% | -40.42% | $4.7 / $0.92 | $2.7 |
Quarterly Results
Figures shown in M / B
| Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | |
|---|---|---|---|---|---|
| Sales | 63.4 M | 61.34 M | 58.47 M | 55.81 M | 54.17 M |
| Operating Profit | -2.16 M | -8.94 M | -10.19 M | -9.32 M | -7.37 M |
| Net Profit | -1.85 M | -8.67 M | -8.71 M | -8.82 M | -6.71 M |
| EPS in Rs | -0.02 | -0.11 | -0.11 | -0.11 | -0.09 |
Profit & Loss
Figures shown in M / B
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Sales | 239.02 M | 204.31 M | 170.47 M | 142.12 M |
| Operating Profit | -30.61 M | -31.41 M | -34.37 M | -49.7 M |
| Net Profit | -28.05 M | -28.35 M | -31.03 M | -49.74 M |
| EPS in Rs | -0.36 | -0.36 | -0.39 | -0.63 |
Balance Sheet
Figures shown in M / B
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Total Assets | 207.97 M | 188.93 M | 201.01 M | 208.35 M |
| Total Liabilities | 125.58 M | 121.96 M | 122.06 M | 125.13 M |
| Equity | 82.38 M | 66.97 M | 78.96 M | 83.22 M |
| Current Assets | 104.99 M | 120.74 M | 129.78 M | 132.89 M |
| Current Liabilities | 84.6 M | 76.62 M | 72.85 M | 72.22 M |
Cash Flow
Last available yearly cash flow history
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Operating CF | 17.54 M | 14.15 M | 10.22 M | -12.77 M |
| Investing CF | -6.85 M | 8.88 M | -7.74 M | -54.03 M |
| Financing CF | -7.33 M | -22.19 M | -13.72 M | -7.21 M |
| Free CF | 12.86 M | 10.36 M | 6.53 M | -15.89 M |
| Capex | -4.68 M | -3.79 M | -3.69 M | -3.13 M |
5Y Margin & Growth History
Last 5 year derived history from yfinance annual statements
| 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|
| Revenue Growth % | 19.85% | 19.95% | — | — |
| Earnings Growth % | 8.65% | 37.61% | — | — |
| Profit Margin % | -13.87% | -18.2% | -35% | — |
| Operating Margin % | -15.37% | -20.16% | -34.97% | — |
| Gross Margin % | 71.4% | 68.1% | 62.51% | — |
| EBITDA Margin % | -5.47% | -7.64% | -22.2% | — |
Dividend & Split History
Latest dividend and stock split events stored from yfinance
Dividend History
No dividend history available.
Stock Splits
No stock split history available.